Leqvio (inclisiran) is a prescription drug used to help treat certain types of high cholesterol. Leqvio comes in a prefilled syringe for injection under the skin. Leqvio contains the active drug ...
Leqvio (inclisiran) may cause injection site reactions, including bruising, pain, discoloration, itchiness, and a burning or prickling sensation at the injection site. In addition to injection site ...
Credit: Novartis. The approval was based on data from the ORION-9, ORION-10, and ORION-11 trials that evaluated Leqvio in patients 18 years of age and older with HeFH or clinical ASCVD. The Food and ...
Sometimes diet and exercise are not enough to lower cholesterol levels. Many different medicine options exist, including Leqvio, which can be used alone or with other medicines to help people reach ...
What Is Leqvio, and Why Does It Matter? Leqvio (inclisiran) is a prescription injection that helps lower levels of low-density lipoprotein cholesterol (LDL), often called “bad” cholesterol, which is a ...
Novartis makes the patient, not the product, the focus in two new DTC spots for cholesterol drug, Leqvio. The two separate ads each feature a protagonist, John and Gloria. The quick cuts convey their ...
Credit: Novartis. The expanded approval now includes patients with comorbidities who have not yet had a first cardiovascular event. The Food and Drug Administration (FDA) has updated the indication ...
Leqvio can now be used alone, without addition of statin therapy, as adjunct to diet and exercise for LDL-C reduction in patients with hypercholesterolemia (high LDL-C) 1 4 out of 5 atherosclerotic ...
Novartis has high hopes for newly launched heart drug Leqvio and cancer therapy Pluvicto. To hear CEO Vas Narasimhan tell it, both products are off to a strong start in their multiyear journeys to ...
Soleo Health Selected by Novartis as Limited Drug Distribution Partner for Administration of LEQVIO®
FRISCO, Texas--(BUSINESS WIRE)--Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has been selected as a limited distribution partner ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results